RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Floyd L. Wormley Jr. to Animals

This is a "connection" page, showing publications Floyd L. Wormley Jr. has written about Animals.
Connection Strength

0.801
  1. Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Mueller M, Wormley FL. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans. Infect Immun. 2015 Dec; 83(12):4513-27.
    View in: PubMed
    Score: 0.041
  2. Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Wormley FL. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J Immunol. 2014 Oct 15; 193(8):4060-71.
    View in: PubMed
    Score: 0.038
  3. Chaturvedi AK, Hameed RS, Wozniak KL, Hole CR, Leopold Wager CM, Weintraub ST, Lopez-Ribot JL, Wormley FL. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice. PLoS One. 2014; 9(8):e104316.
    View in: PubMed
    Score: 0.038
  4. Wozniak KL, Hole CR, Yano J, Fidel PL, Wormley FL. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection. Microbiology (Reading). 2014 Jul; 160(Pt 7):1440-1452.
    View in: PubMed
    Score: 0.037
  5. Chaturvedi AK, Weintraub ST, Lopez-Ribot JL, Wormley FL. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses. Proteomics. 2013 Dec; 13(23-24):3429-41.
    View in: PubMed
    Score: 0.036
  6. Wozniak KL, Kolls JK, Wormley FL. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by ?d T cells. BMC Immunol. 2012 Dec 07; 13:65.
    View in: PubMed
    Score: 0.034
  7. Hole CR, Bui H, Wormley FL, Wozniak KL. Mechanisms of dendritic cell lysosomal killing of Cryptococcus. Sci Rep. 2012; 2:739.
    View in: PubMed
    Score: 0.033
  8. Hardison SE, Herrera G, Young ML, Hole CR, Wozniak KL, Wormley FL. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J Immunol. 2012 Oct 15; 189(8):4060-8.
    View in: PubMed
    Score: 0.033
  9. Steele C, Wormley FL. Immunology of fungal infections: lessons learned from animal models. Curr Opin Microbiol. 2012 Aug; 15(4):413-9.
    View in: PubMed
    Score: 0.033
  10. Walraven CJ, Gerstein W, Hardison SE, Wormley F, Lockhart SR, Harris JR, Fothergill A, Wickes B, Gober-Wilcox J, Massie L, Ku TS, Firacative C, Meyer W, Lee SA. Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One. 2011; 6(12):e28625.
    View in: PubMed
    Score: 0.031
  11. Wozniak KL, Hardison S, Olszewski M, Wormley FL. Induction of protective immunity against cryptococcosis. Mycopathologia. 2012 Jun; 173(5-6):387-94.
    View in: PubMed
    Score: 0.031
  12. Wozniak KL, Young ML, Wormley FL. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol. 2011 May; 18(5):717-23.
    View in: PubMed
    Score: 0.030
  13. Wozniak KL, Hardison SE, Kolls JK, Wormley FL. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One. 2011 Feb 17; 6(2):e17204.
    View in: PubMed
    Score: 0.030
  14. Hardison SE, Wozniak KL, Kolls JK, Wormley FL. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect Immun. 2010 Dec; 78(12):5341-51.
    View in: PubMed
    Score: 0.029
  15. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol. 2010 Feb; 176(2):774-85.
    View in: PubMed
    Score: 0.028
  16. Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One. 2009 Sep 03; 4(9):e6854.
    View in: PubMed
    Score: 0.027
  17. Young M, Macias S, Thomas D, Wormley FL. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics. 2009 May; 9(9):2578-88.
    View in: PubMed
    Score: 0.026
  18. Wormley FL, Perfect JR, Steele C, Cox GM. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect Immun. 2007 Mar; 75(3):1453-62.
    View in: PubMed
    Score: 0.022
  19. Wormley FL, Heinrich G, Miller JL, Perfect JR, Cox GM. Identification and characterization of an SKN7 homologue in Cryptococcus neoformans. Infect Immun. 2005 Aug; 73(8):5022-30.
    View in: PubMed
    Score: 0.020
  20. Wormley FL, Cox GM, Perfect JR. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain. Microb Pathog. 2005 Feb-Mar; 38(2-3):113-23.
    View in: PubMed
    Score: 0.020
  21. Wormley FL, Perfect JR. Immunology of infection caused by Cryptococcus neoformans. Methods Mol Med. 2005; 118:193-8.
    View in: PubMed
    Score: 0.019
  22. Wormley FL, Cutright J, Fidel PL. Multiple experimental designs to evaluate the role of T-cell-mediated immunity against experimental vaginal Candida albicans infection. Med Mycol. 2003 Oct; 41(5):401-9.
    View in: PubMed
    Score: 0.018
  23. Wozniak KL, Wormley FL, Fidel PL. Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect Immun. 2002 Oct; 70(10):5790-9.
    View in: PubMed
    Score: 0.017
  24. Wormley FL, Steele C, Wozniak K, Fujihashi K, McGhee JR, Fidel PL. Resistance of T-cell receptor delta-chain-deficient mice to experimental Candida albicans vaginitis. Infect Immun. 2001 Nov; 69(11):7162-4.
    View in: PubMed
    Score: 0.016
  25. Wormley FL, Chaiban J, Fidel PL. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis. Infect Immun. 2001 Aug; 69(8):5072-9.
    View in: PubMed
    Score: 0.015
  26. Wormley FL, Scott M, Luo W, Baker M, Chaiban J, Fidel PL. Evidence for a unique expression of CD4 on murine vaginal CD4+ cells. Immunology. 2000 Jul; 100(3):300-8.
    View in: PubMed
    Score: 0.014
  27. Fidel PL, Luo W, Steele C, Chabain J, Baker M, Wormley F. Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect Immun. 1999 Jun; 67(6):3135-40.
    View in: PubMed
    Score: 0.013
  28. Zhai B, Wozniak KL, Masso-Silva J, Upadhyay S, Hole C, Rivera A, Wormley FL, Lin X. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants. mBio. 2015 Oct 06; 6(5):e01433-15.
    View in: PubMed
    Score: 0.010
  29. Eastman AJ, He X, Qiu Y, Davis MJ, Vedula P, Lyons DM, Park YD, Hardison SE, Malachowski AN, Osterholzer JJ, Wormley FL, Williamson PR, Olszewski MA. Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarization. J Immunol. 2015 Jun 15; 194(12):5999-6010.
    View in: PubMed
    Score: 0.010
  30. Rane HS, Hardison S, Botelho C, Bernardo SM, Wormley F, Lee SA. Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis. Virulence. 2014; 5(8):810-8.
    View in: PubMed
    Score: 0.010
  31. Feretzaki M, Hardison SE, Wormley FL, Heitman J. Cryptococcus neoformans hyperfilamentous strain is hypervirulent in a murine model of cryptococcal meningoencephalitis. PLoS One. 2014; 9(8):e104432.
    View in: PubMed
    Score: 0.009
  32. Yano J, Kolls JK, Happel KI, Wormley F, Wozniak KL, Fidel PL. The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway. PLoS One. 2012; 7(9):e46311.
    View in: PubMed
    Score: 0.008
  33. Chaturvedi AK, Lazzell AL, Saville SP, Wormley FL, Monteagudo C, Lopez-Ribot JL. Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease. PLoS One. 2011; 6(5):e20449.
    View in: PubMed
    Score: 0.008
  34. Onyewu C, Wormley FL, Perfect JR, Heitman J. The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicans. Infect Immun. 2004 Dec; 72(12):7330-3.
    View in: PubMed
    Score: 0.005
  35. Blankenship JR, Wormley FL, Boyce MK, Schell WA, Filler SG, Perfect JR, Heitman J. Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryot Cell. 2003 Jun; 2(3):422-30.
    View in: PubMed
    Score: 0.004
  36. C?rdenas-Freytag L, Steele C, Wormley FL, Cheng E, Clements JD, Fidel PL. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G). Med Mycol. 2002 Jun; 40(3):291-9.
    View in: PubMed
    Score: 0.004
  37. Kelly KA, Gray HL, Walker JC, Rank RG, Wormley FL, Fidel PL. Chlamydia trachomatis infection does not enhance local cellular immunity against concurrent Candida vaginal infection. Infect Immun. 2001 May; 69(5):3451-4.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support